• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarUSA Market OverviewCanada Market OverviewEurope Market Overview
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of MBIO

MUSTANG BIO INC (MBIO) Stock News

USA - NASDAQ:MBIO - US62818Q3020 - Common Stock

1.58 USD
+0.01 (+0.64%)
Last: 9/12/2025, 8:00:01 PM
1.6146 USD
+0.03 (+2.19%)
After Hours: 9/12/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

MBIO Latest News, Press Relases and Analysis

All
Press Releases
2 months ago - By: Benzinga - Mentions: JAGX WINT PRPO DARE ...
News Image

12 Health Care Stocks Moving In Monday's Pre-Market Session

2 months ago - By: Benzinga - Mentions: WINT VRNA KZIA RLYB ...
News Image

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

2 months ago - By: FN Media Group LLC - Mentions: ONCY ONC.CA VSTM CRDF ...
News Image

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

2 months ago - By: Stocktwits
News Image

Mustang Bio Ignites Bullish Retail Buzz As FDA Grants Orphan Status To Brain Cancer Drug

2 months ago - By: Mustang Bio, Inc.
News Image

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

6 months ago - By: Mustang Bio, Inc.
News Image

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement